Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-01-25FDA Approved: PIRFENIDONE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's generic pirfenidone as an original application for the treatment of idiopathic pulmonary fibrosis.
-
FDA approval · 2022-01-03FDA Approved: PIRFENIDONE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic version of pirfenidone (ANDA 212569) for idiopathic pulmonary fibrosis, manufactured by Amneal Pharmaceuticals NY LLC…
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 results update for a therapy intended to reduce autoantibodies in patients with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Treatment of IPF With Laparoscopic Anti-Reflux Surgery [NA]
A completed clinical trial evaluating laparoscopic anti-reflux surgery as a treatment approach in patients with idiopathic pulmonary fibrosi…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial evaluating GLPG1205 for Idiopathic Pulmonary Fibrosis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 4]
Phase 4 clinical trial evaluating pulmonary rehabilitation in idiopathic pulmonary fibrosis was terminated, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) [Phase 2]
Phase 2 study of Gefapixant (MK-7264) in idiopathic pulmonary fibrosis patients with persistent cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients [Phase 1, Phase 2]
The study reports completed Phase 1/Phase 2 results for TD139 versus placebo in idiopathic pulmonary fibrosis patients, with results posted …
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period [NA]
A completed clinical trial studying the disease behavior of idiopathic pulmonary fibrosis and interstitial lung disease during the peri-diag…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: CleanUP IPF for the Pulmonary Trials Cooperative [Phase 3]
Phase 3 trial of CleanUP IPF for Idiopathic Pulmonary Fibrosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: SD, IL-13 Production Rate in IPF [Phase 2]
Phase 2 trial update in idiopathic pulmonary fibrosis investigating SD and IL-13 production rate.
-
CLINICAL_TRIALS research · 2020-12-17Clinical Trial Update: A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
A completed clinical trial analyzing medical records to characterize idiopathic pulmonary fibrosis patients based on the type of medication …
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). [Phase 3]
Open-label Phase 3 trial assessing pirfenidone for idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of BG00011 in idiopathic pulmonary fibrosis was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating pirfenidone combined with sildenafil in advanced idiopathic pulmonary fibrosis with potential pulmonary hypertens…
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial assessing safety, tolerability, PK and PD of GLPG1690 in idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study
Clinical trial update for the OASIS-IPF study in idiopathic pulmonary fibrosis; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF [Phase 2]
Phase 2 trial evaluating safety and tolerability of GBT440 in IPF patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial update on treprostinil for patients with pulmonary arterial hypertension associated with interstitial lung disease, including …
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial assessing safety and efficacy of pamrevlumab (FG-3019) in idiopathic pulmonary fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest [Phase 2]
Phase 2 study evaluating GBT440 in subjects with idiopathic pulmonary fibrosis on supplemental oxygen was terminated; results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Morphine for Dyspnea in Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial update evaluating morphine for dyspnea in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial update on SAR156597 for idiopathic pulmonary fibrosis reports efficacy and safety data post-completion.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial of STX-100 in idiopathic pulmonary fibrosis (IPF) has completed and results were posted in 2020.
-
CLINICAL_TRIALS research · 2020-01-27Clinical Trial Update: Digital Auscultation Test - IPF Data Collection [Phase 4]
A Phase 4 trial update collecting data on a digital auscultation test for idiopathic pulmonary fibrosis after completion.